The device combines multiple wave energies and can be used to destroy malignant cells more effectively than existing audio frequency devices.
The invention relates to a system and method for providing ultrasound therapy at multiple user-selectable frequencies using one applicator sound head, as well as methods for identifying therapeutic resonant frequencies.
Methods of determining resonant frequencies
electromagnetic waves have long been used to control atomic and molecular particles, including bacteria cells and diseased tissue. For maximum effectiveness, therapeutic resonant frequencies must match those naturally resonating with materials; to do this accurately, methods have been devised that allow precise determination of therapeutic frequencies that better reflect natural resonance frequencies of materials – including providing more precise results than trial-and-error techniques and also allow the identification of specific genomic materials, atoms or molecules requiring therapy.
Researchers used magnetic resonance imaging (MRI) on mouse tumor-bearing mice with cancerous tumors and measured their resonant frequencies using magnetic resonance imaging systems, before treating with drugs that activate protein phosphatase 2A (PP2A) enzyme activators drug to decrease tumor resonant frequencies; suggesting their importance in cancerous tumor development.
Methods used for determining resonant frequencies take into account the refractive index of the medium in which genomic material, atoms or molecules are being utilized. This allows for more precise and accurate correlations between their findings and natural or therapeutic resonance frequencies of materials being studied.
Researchers used magnetic resonance imaging machines to conduct studies on mice carrying flank tumors of human neuroblastoma cells from SK-N-AS strain, and measured the resonant frequencies using computer software. Tumor resonant frequencies differed significantly from those in normal tissues due to higher concentrations of phosphorus present within tumors, leading to more vibrational modes being activated than usual tissues.
These techniques of detecting resonant frequencies also have applications outside the laboratory, such as producing compressional pulses within living organisms. They involve shaping an overmodulated audio wave in a radio transmitter and sending its vibrational frequencies through a gas-filled tube; when they encounter target tissues they will resonate and cause them to vibrate causing them to reflect back to the source where they can then be detected and utilized for various biophysiologic effects.
Devices for determining resonant frequencies
This invention concerns devices for identifying therapeutic resonant frequencies through sound wave energy. These devices utilize modulated audio frequencies to produce electromagnetic waves with wavelengths in the ultrasonic range that exert compressional forces inside cells and organisms, inhibiting microbial growth while treating diseases or conditions. Furthermore, the devices also generate subharmonic frequencies multiples of fundamental frequencies; such frequencies can be more effective at modulating genetic activity than fundamental frequencies alone.
Determining resonant frequencies with this method is much simpler and faster than using trial-and-error. Furthermore, it takes into account an appropriate electromagnetic refractive index of a medium and allows for faster identification of therapeutic resonance frequencies.
This patented technology can be used to effectively prevent or destroy microorganisms such as viruses, bacteria and parasites. It works by shaping an overmodulated radio wave pulse from a transmitter and sending it down a gas-filled tube, where its overmodulated form creates a wave form capable of penetrating into tissues within the body to produce physiological effects.
To identify the resonant frequency of genomic material, the length of DNA or RNA biomolecular chains is measured; this provides a wavelength measurement specific to that piece of genomic material. Furthermore, nucleotide base pairs in DNA double helixs can also be measured and utilized to ascertain frequency measurements.
Once a resonant frequency has been identified, the next step should be comparing it with other frequencies in order to find its resonance point – where an amplitude difference exists between two frequencies and then finding their respective resonant frequency characteristics of interest by comparison. Once found, this step allows devices such as ultrasound to locate it easily. Once found, devices then determine its resonance frequency characteristics relative to other frequencies for target material evaluation purposes and compares their amplitude frequency characteristics against each other in order to locate resonance points and establish resonance points by comparison between themselves compared with them and then finding its resonant frequency characteristics by comparison between its amplitude frequency characteristics with others frequencies compared with each frequency that has its amplitude frequency characteristic when compared with others. Once established this step allows devices to locate resonance points where amplitude differences exist between one frequency is larger than another when amplitude differences occur in terms of comparison of material related to target material comparison; device will then determine its resonant frequency by comparing its amplitude frequency characteristic with others and determine its resonant frequency characteristics with others frequencies to find its resonant frequency characteristic of any target material comparison to other frequencies used in measurements taken of target material characteristics versus others found.
This patented technology combines diverse wave energies to generate composite energy waves capable of breaking down and killing microorganisms without harming healthy tissue, providing a safer way of treating illnesses and diseases. Furthermore, this method may even be used to inhibit cell malignancy by disrupting cancerous cell mitosis without harming healthy cells or tissues during mitosis.
Devices for generating resonant frequencies
Resonant frequencies generators use electromagnetic energy to interact with genomic materials such as DNA and RNA, producing bio-physiologic effects on cells and microorganisms that either inhibit, debilitate or stimulate them depending on the frequency used. Their effectiveness depends on both ease of identification as well as efficiency when used with suitable devices and delivery systems.
Existing devices can identify resonant frequencies for specific genome materials, but may not always have access to those frequencies for use with their frequency-emitting devices. This is usually due to needing long coaxial cables between components such as radio transmitter and amplifier/tuner; such cables degrade pulse envelope quality and decrease modulation frequency pass band pass rates significantly. An improved device would eliminate such long lengths of coaxial cable completely while greatly improving operational attributes by many orders of magnitude.
Improvements to this device involve installing a new transmitter and accessory components that enable it to output higher frequency ranges without degrading its pulse envelope. With these upgrades in place, this improved device is capable of producing compressional waves extending into ultrasonic range, which can then be directed toward tumors or viral infections in various parts of the body; their vibrations create beat frequencies within cells or organisms that resonate with their DNA or RNA structures and resonate back.
The device also allows users to identify resonant frequencies for smaller portions of DNA or constituent components within a genome, so they can more precisely target their treatment of DNA/RNA that needs treating. Furthermore, users can program this device to select optimal frequencies for any given patient while monitoring how effective treatment has been.
The new transmitter and its attached components boast much faster rise and fall times than their existing device, enabling shorter pulses with higher modulation frequencies to be produced more quickly than before. This upgrade significantly boosts modulation capability, commercial viability and the creation of physiological effects by many times over.
Methods of generating resonant frequencies
Many therapeutic devices emit not only their basic frequency – known as the fundamental frequency – but also multiple harmonic frequencies, known as harmonic multiples of fundamental frequency, that provide more effective methods of modulating genetic activity. Resonant frequencies are created by dividing fundamental frequency by positive integer to determine harmonics and subharmonics; then these frequencies can be programmed into frequency emitting devices to be released when targeting genomic material.
Resonant frequency of an object correlates with its length and can be detected within its environment. DNA/RNA chains possess natural resonant frequencies correlated to their length which interact with electromagnetic waves in which they are immersed, emitting energy waves that are detectable by human bodies and can even prevent diseases and conditions that affect humans or animals as well as agriculture, water systems, food processing facilities etc. This technology can be applied in many applications for prevention or treatment of microbiological and biochemical events including human and animal illnesses as well as agriculture systems water systems food processing systems etc.
This invention describes a method for determining resonant frequencies for molecules and cells using the fact that their structures emit frequencies with differing wavelengths depending on their structures. In particular, WatsonCrick model of base pair spacing offers a convenient method of translating DNA linear length into its frequency in electromagnetic spectrum; using this information to identify resonant frequencies useful in diagnosing therapeutic effects on these molecules.
Method of the present invention may also be utilized to generate lower audio range resonant frequencies. To do this, an initial therapeutic resonant frequency can be divided by 2, or some power of two as necessary until reaching audio-range resonant frequencies that resonate. These related frequencies are known as octaves in music and will resonate as such when placed next to each other.
This patent describes an improved frequency therapy device which allows for higher frequency transmissions with reduced degradation to pulse envelope. This is achieved using a new transmitter with its associated components – amplifier, tuner, plasma tube antenna type. Furthermore, this device boasts rise and fall times of up to 40 nanoseconds compared to existing devices – a substantial advancement.
